Position in ZVRA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$3,933,487
+$1,375,516 QoQ
Shares Held
422,048
+47.8% QoQ
Ownership
0.714%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 99.00698498748957.ToString("F0")%
Shared 0.ToString("F0")%
None 0.9930150125104253.ToString("F0")%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. ZVRA ranks #162 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in ZVRA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,933,487 | 422,048 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,557,971 | 285,488 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,074,092 | 218,096 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,358,361 | 154,184 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,221,349 | 163,064 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,867,442 | 343,818 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $138,341 | 19,934 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $63,366 | 12,932 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $249,098 | 42,948 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $229,970 | 35,110 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $90,336 | 18,742 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $102,469 | 20,092 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $22,764 | 4,139 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $32,042 | 6,981 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $6,096 | 977 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $25,859 | 5,798 | Shares | Sole | 2022-08-10 | |
| 2021-12-31 | $91,445 | 10,499 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $122,203 | 13,283 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||